Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 22

1.

Randomised trial of efficacy of benznidazole in treatment of early Trypanosoma cruzi infection.

de Andrade AL, Zicker F, de Oliveira RM, Almeida Silva S, Luquetti A, Travassos LR, Almeida IC, de Andrade SS, de Andrade JG, Martelli CM.

Lancet. 1996 Nov 23;348(9039):1407-13.

PMID:
8937280
2.

Course of Chronic Trypanosoma cruzi Infection after Treatment Based on Parasitological and Serological Tests: A Systematic Review of Follow-Up Studies.

Sguassero Y, Cuesta CB, Roberts KN, Hicks E, Comandé D, Ciapponi A, Sosa-Estani S.

PLoS One. 2015 Oct 5;10(10):e0139363. doi: 10.1371/journal.pone.0139363. eCollection 2015. Review.

3.

Side effects of benznidazole as treatment in chronic Chagas disease: fears and realities.

Viotti R, Vigliano C, Lococo B, Alvarez MG, Petti M, Bertocchi G, Armenti A.

Expert Rev Anti Infect Ther. 2009 Mar;7(2):157-63. doi: 10.1586/14787210.7.2.157. Review.

PMID:
19254164
4.

Trypanocidal drugs for chronic asymptomatic Trypanosoma cruzi infection.

Villar JC, Marin-Neto JA, Ebrahim S, Yusuf S.

Cochrane Database Syst Rev. 2002;(1):CD003463. Review. Update in: Cochrane Database Syst Rev. 2014;5:CD003463.

PMID:
11869663
5.

Chagas disease and the US blood supply.

Bern C, Montgomery SP, Katz L, Caglioti S, Stramer SL.

Curr Opin Infect Dis. 2008 Oct;21(5):476-82. doi: 10.1097/QCO.0b013e32830ef5b6. Review.

PMID:
18725796
6.

[Treatment of Trypanosoma cruzi infection in the indeterminate phase: experience and current guidelines in Argentina].

Sosa Estani S, Segura EL.

Medicina (B Aires). 1999;59 Suppl 2:166-70. Review. Spanish.

PMID:
10668259
7.

Recent clinical trials for the etiological treatment of chronic chagas disease: advances, challenges and perspectives.

Urbina JA.

J Eukaryot Microbiol. 2015 Jan-Feb;62(1):149-56. doi: 10.1111/jeu.12184. Epub 2014 Nov 13. Review.

PMID:
25284065
8.

[Update on the treatment of Chagas' disease].

Apt W, Zulantay I.

Rev Med Chil. 2011 Feb;139(2):247-57. doi: /S0034-98872011000200016. Epub 2011 Jul 11. Review. Spanish.

9.

Current status of Chagas disease chemotherapy.

Guedes PM, Silva GK, Gutierrez FR, Silva JS.

Expert Rev Anti Infect Ther. 2011 May;9(5):609-20. doi: 10.1586/eri.11.31. Review.

PMID:
21609270
10.

Nanomedicines against Chagas disease: an update on therapeutics, prophylaxis and diagnosis.

Morilla MJ, Romero EL.

Nanomedicine (Lond). 2015 Feb;10(3):465-81. doi: 10.2217/nnm.14.185. Review.

PMID:
25707979
11.

Modulation of Trypanosoma cruzi-specific T-cell responses after chemotherapy for chronic Chagas disease.

Albareda MC, Laucella SA.

Mem Inst Oswaldo Cruz. 2015 May;110(3):414-21. doi: 10.1590/0074-02760140386. Review.

12.

Toxic side effects of drugs used to treat Chagas' disease (American trypanosomiasis).

Castro JA, de Mecca MM, Bartel LC.

Hum Exp Toxicol. 2006 Aug;25(8):471-9. Review.

PMID:
16937919
13.

Current drug therapy and pharmaceutical challenges for Chagas disease.

Bermudez J, Davies C, Simonazzi A, Real JP, Palma S.

Acta Trop. 2016 Apr;156:1-16. doi: 10.1016/j.actatropica.2015.12.017. Epub 2015 Dec 30. Review.

PMID:
26747009
14.

Chronic Chagas disease with advanced cardiac complications in Japan: Case report and literature review.

Imai K, Maeda T, Sayama Y, Osa M, Mikita K, Kurane I, Miyahira Y, Kawana A, Miura S.

Parasitol Int. 2015 Oct;64(5):240-2. doi: 10.1016/j.parint.2015.02.005. Epub 2015 Mar 3. Review.

PMID:
25744336
15.

First century of Chagas' disease: an overview on novel approaches to nifurtimox and benzonidazole delivery systems.

Salomon CJ.

J Pharm Sci. 2012 Mar;101(3):888-94. doi: 10.1002/jps.23010. Epub 2011 Dec 12. Review.

PMID:
22161779
16.

Targets and Patented Drugs for Chemotherapy of Chagas Disease in the Last 15 Years-Period.

Duschak VG.

Recent Pat Antiinfect Drug Discov. 2016;11(2):74-173. doi: 10.2174/1574891X11666161024165304. Review.

PMID:
27784230
17.

Pediatric clinical pharmacology studies in Chagas disease: focus on Argentina.

Garcia-Bournissen F, Altcheh J, Giglio N, Mastrantonio G, Della VĂ©dova CO, Koren G.

Paediatr Drugs. 2009;11(1):33-7. Review.

PMID:
19127950
18.

Biomarkers of therapeutic responses in chronic Chagas disease: state of the art and future perspectives.

Pinazo MJ, Thomas MC, Bustamante J, Almeida IC, Lopez MC, Gascon J.

Mem Inst Oswaldo Cruz. 2015 May;110(3):422-32. doi: 10.1590/0074-02760140435. Epub 2015 Apr 28. Review.

19.

Chagas disease.

Rassi A Jr, Rassi A, Marin-Neto JA.

Lancet. 2010 Apr 17;375(9723):1388-402. doi: 10.1016/S0140-6736(10)60061-X. Review.

PMID:
20399979
20.

Chagas disease: review of needs, neglect, and obstacles to treatment access in Latin America.

Pinheiro E, Brum-Soares L, Reis R, Cubides JC.

Rev Soc Bras Med Trop. 2017 May-Jun;50(3):296-300. doi: 10.1590/0037-8682-0433-2016. Review.

Supplemental Content

Support Center